Communicable disease threats report, 19-25 September, week 39
September 26, 2026
Data collection on COVID-19 outbreaks in closed settings a with completed vaccination programme: long-term care facilities
The main aim of this activity is to collect information on the severity of breakthrough COVID-19 infections in outbreaks, by SARS-CoV-2 variant and vaccine product.
Considerations on the use of rapid antigen detection (including self-) tests for SARS-CoV-2 in occupational settings
This document outlines the public health considerations for the use of rapid antigen detection tests (RADTs), including self-test RADTs to detect SARS-CoV-2 in individuals in occupational settings in the European Union/European Economic Area (EU/EEA), and provides information on the use of such tests in an occupational safety and health at work context.
Stop the spread! Could diagnostic antigen tests help control COVID-19 transmission in workplaces?
ECDC has joined forces with EU-OSHA, the EU agency for occupational safety and health, to explore the use of rapid antigen tests for SARS-CoV-2, the virus that causes COVID-19, in the workplace.
Infographic: rapid antigen tests for SARS-CoV-2 in the workplace
Joint ECDC – EU-OSHA infographic on the use of rapid antigen tests for SARS-CoV-2, the virus that causes COVID-19, in the workplace.
Guidance for representative and targeted genomic SARS-CoV-2 monitoring
This document offers practical guidance for EU/EEA Member States on implementing genomic SARS-CoV-2 surveillance. It also includes advice on how to estimate the number of sequenced samples needed to achieve various objectives, including the early detection of novel variants.
Considerations for the use of saliva as sample material for COVID-19 testing
This document outlines the use of saliva as a diagnostic sample for detecting SARS-CoV-2 infection, considering the advantages, limitations and uncertainties associated with the use of saliva as sample material.
